期刊文献+

库肯勃瘤中CD44v6﹑VEGF﹑MMP-2﹑MMP-9的表达及相关性研究 被引量:2

Expression and Relativity Study of CD44v6,VEGF,MMP-2 and MMP-9 in Krukenberg Tumor
下载PDF
导出
摘要 目的:探讨CD44v6、VEGF、MMP-2、MMP-9在库肯勃瘤及卵巢原发上皮癌中的表达及相关性。方法:应用免疫组化SP法检测CD44v6、VEGF、MMP-2、MMP-9在20例正常卵巢组织、38例库肯勃瘤、45例卵巢原发上皮癌中的表达情况。结果:CD44v6、VEGF在卵巢原发上皮癌和库肯勃瘤组织中的表达显著高于正常卵巢组织(P<0.05);MMP-2﹑MMP-9在正常卵巢组织中表达缺如;CD44v6、VEGF、MMP-2、MMP-9在库肯勃中阳性表达率明显高于卵巢原发上皮癌(P<0.05)。CD44v6、VEGF、MMP-2、MMP-9在卵巢原发上皮性癌、库肯勃瘤中,任意两指标阳性表达均有正相关性(P<0.05)。结论:CD44v6、VEGF、MMP-2、MMP-9均参与卵巢癌、胃癌、库肯勃瘤的发生、发展及演进过程,并可为卵巢上皮癌、胃癌及库肯勃瘤的鉴别诊断提供一定依据。 Objective: To explore expression and relativity of CD44v6, VEGF, MMP-2 and MMP-9 in Krukenberg and the primary epithelial ovarian carcinoma. Methods: The expressions of CD44v6, VEGF, MMP-2 and MMP-9 were detected by immunohistochemistry S-P method in the 20 cases of normal ovarian tissues, 38 cases with Krukenberg tumor and 45 cases with primary epithelial ovarian carcinoma. Results: The expressions of CD44v6 and VEGF were significantly higher in primary epithelial ovarian carcinoma tissues and Krukenberg tumor tissues than in normal ovarian tissues (P〈0.05). The positive expression rates of MMP-2 and MMP-9 were zero in the normal ovarian tissues. The positive expression rates of CD44v6, VEGF, MMP-2 and MMP-9 were remarkably higher in the Krukenberg tumor than in primary epithelial ovarian carcinoma (P〈0.05). Relativity has been observed for CD44v6, VEGF, MMP-2 and MMP-9 each other in primary epithelial ovarian carcinomas and in Krukenberg tumors (/〈0.05). Conclusion: CD44v6, VEGF, MMP-2 and MMP-9 were concerned with evolvement process for ovarian carcinoma, gastric cancer and Krukenberg tumor. Detection of CD44v6, VEGF, MMP-2 and MMP-9 may offer basis of diagnosis ovarian carcinoma, gastric cancer and Krukenberg tumor.
作者 高颖 娄阁
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第24期1381-1385,共5页 Chinese Journal of Clinical Oncology
基金 教育部出国留学人员基金(编号:[2003]406) 黑龙江省教育厅科研基金项目资助(编号:9551138)
关键词 卵巢肿瘤 KRUKENBERG瘤 CD44V6 VEGF MMPS Ovarian neoplasms Krukenberg tumor CD44v6 VEGF MMPs
  • 相关文献

参考文献2

二级参考文献5

  • 1李宏,J Cancer,1995年,72卷,160页
  • 2李宏,Cancer Res,1993年,53卷,5345页
  • 3Giobron MA, Cotran RS, Leapman et al. Tumor growth and neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst, 1974,72:413-430.
  • 4Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in performed and newly formed blood vessels during tumor angiogenesis. Microvasc Res, 1977, 14: 53-65.
  • 5Brem S, Brem H, Folkman J, et al. Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res, 1976,36: 2807-2820.

共引文献61

同被引文献17

  • 1Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis[J]. J Natl Cancer Inst, 1997,89(17) : 1260 -1270.
  • 2Koshikawa N, Giannelli G, Cirulli V, et al.Role of cell surface metallopro teinase MT1 -MMP in epithelial cell migration over lam inin-5[J]. J Cell Biol, 2000, 148 (3):615-624.
  • 3Gschwend JE, Fair WR, Vieweg J. Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies [ J ].Eur Urol,2000,38(2) : 121 - 130.
  • 4Artigas F, Romero L, De Montigny C, et al. Accelertion of the effect of selected antidepressant drugs in major depression by 5 - HT1A antagonists[J]. Trends Neurisci, 1996, 19(9):378 -383.
  • 5Murray GI. Matrix metaloproteinases: a multifunctional group of molecules [ J ]. J Pathol, 2001,195(2) : 135 - 137.
  • 6Jouce ER. Matrix M et,al.lop ro teinases. A ngiogenesis, and Cancer Clinical [ J ]. Cancer Research, 2003,549:551.
  • 7Loukopoulos P, Mungall BA, Straw RC, et al.Matrix metallopro - teinase - 2 and - 9 involvement in canine tumors [ J ]. Vet Pathol, 2003,40(4) :382 - 394.
  • 8Akahara H, Howard L, Erik W, et al. Transmembrane/cytoplasmic domain- mediated membrane type 1 - matrix metalloprotease docking to invadopodia is required for cell invasion [ J ].Proc Natl Acad Sci USA, 1997, 94-7959 -7964.
  • 9Chenard MP, Lutz Y, Mechine Neuville A, et al.Presence of high levels of MT1 - MMP protein in fibroblastic cells of human invasive carcinomas[J]. Int J Cancer, 1999,82 (2) :208-212.
  • 10Ruokolainen H, Paakko P, Turpeenniemi -Hujanen T. Tissue and circulating immunoreactive protein for MMP - 2 and TIMP - 2 in head and neck squamous cell carcinomatissue immunoreactivity predicts aggressive clinical course[J]. Mod Pathol, 2006, 19(2):208 -217.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部